treatment preferences of recently diagnosed patients, and how these evolve over time. A Belgian qualitative study has set the scene (1), but knowledge on cross-cultural nuances in patient-preferred outcomes is lacking. To this end, EQPERA -European Qualitative research collaboration on Patient-preferred outcomes in Early Rheumatoid Arthritis-was founded. Objectives: EQPERA aims to unravel longitudinally preferences for treatment and health outcomes among patients with early RA across Belgium, the Netherlands and Sweden. To yield sound results, specific preparations for this cross-country qualitative study are reported here. Methods: Several steps have been undertaken to ensure trustworthiness of findings and consistency across countries in sampling, interviewing, analysis and project management: a detailed research protocol has been written; the interview guides have been translated following a structured forward-backward linguistic validation process; templates for data collection and a quality assurance reporting tool have been developed; and local staff has been trained and supervised by the project leader in implementing the study protocol. Each country will document changes with sufficient detail in their research logbook. Results: EQPERA will be a qualitative, explorative, longitudinal study with active involvement of patient researchers. In each country, a purposive sample of patients with early RA will be individually interviewed 3-6 months after start of the initial RA treatment and subsequently, the same participants will be invited back to take part in a focus group 12-18 months after RA treatment initiation. Data collection and analysis will be independently conducted by the local research teams in their native language. The local teams will analyze their interview data using the constant comparison method as detailed in Qualitative analysis guide of Leuven, after which Saldana's guiding questions will be adopted for analyzing change over time. Afterwards, a meta-synthesis of all locally gathered and interpreted data will be conducted to explore and describe patterns, similarities and differences across countries.
Conclusions:
This European project is a first step in gathering contextual findings on patient-preferred outcomes in early RA. Such knowledge is of crucial importance for tailoring therapeutic approaches in a timely and meaningful way. Our innovative, qualitative, longitudinal research design goes beyond the abilities of the frequently used cross-sectional designs in qualitative research. Large, multi-national qualitative projects are scarce in rheumatology research, thus applied data management and quality assurance strategies could be of interest to other researchers. Background: The recently published EULAR recommendations for patient education (PE) in people with inflammatory Arthritis (IA) encompass two overarching principles and eight recommendations (1). The average overall agreement of PE experts with the recommendations is usually high (at least 8.8 (SD+/-0.5) on a 1-10 Numeric Rating Scale NRS) (1, 2). The recommendations ought to be disseminated and implemented to establish a core standard for delivering PE and training for health professionals (HPs) in delivering PE across Europe. Objectives: The Swiss HPs in rheumatology organisation, hpr Switzerland, aimed to evaluate the current standard of PE as well as the agreement with and application of the EULAR PE recommendations in Switzerland, in order to develop further implementation steps. Methods: An online survey was conducted among HPs and rheumatologists in the major rheumatology clinics (n=28) of the German and French part in Switzerland. The current knowledge and skills in PE and the performance of PE in clinical practice were assessed by multiple choice questions. The agreement with the PE recommendations was assessed on a 1-10 NRS and their application in the rheumatology clinics on a 4-point scale ("applied"/"rather applied"/"rather not applied"/"not applied"). Results: A total of 57 HPs, among them 12 rheumatologists, 21 nurses, 15 physiotherapists, 6 occupational therapists, 2 medical assistants) from 12 rheumatology clinics participated. Of these HPs, 31 (55%) worked for more than 6 years in rheumatology and 15 (27%) indicated to have a formal training in PE. They perceived that PE formed a substantial part of their work (33.5% on average), the most important element being "providing information" (48%), compared to 27% counselling and 25% behavioural interventions. The average overall agreement with the PE recommendations was 7.0 (SD+/-2.25). Recommendations 3 and 7 were well applied (72%) in the rheumatology clinics. Least applied were the recommendations 4 and 6 with 21% and 24% respectively. Recommendations 1, 2, 5 and 8 reached between 40-50% application rates. Image/graph shows Agreement with and Application of the PE Recommendations in Switzerland
Conclusions: The overall agreement with the recommendations was high, although lower than the overall agreement of PE experts (1,2). The application of most recommendations was found to be moderate to low in Swiss rheumatology institutions; however no comparisons with other countries are available. "Providing information" was reported as the most important PE element. This emphasises the need to implement the PE recommendations as well as to improve HPs' knowledge on delivering and evaluating effective PE, in order to provide beneficial PE interventions for people with IA in Switzerland. Results: Sixty two patients were randomly assigned to the each group.The groups were similar in sociodemographical feature (p>0.05). Improvements in mobility, quality of life and daily physical activity levels were found in the study group (p<0.05). There were no significant differences between control and intervention group in length of stay in hospital (p>0.05).
These results revealed the necessity of physiotherapy and rehabilitation program to prevent negative effects of the hospitalization process of the geriatric patients with osteoporosis. Background: EULAR recommendation 3 for the role of the nurse in the management of chronic inflammatory arthritis states that patients should have access to nurse-led telephone services to enhance continuity of care and to provide ongoing support (1). In the UK quality standard 6 of the National Institute for Health and Care Excellence guidelines for the care of rheumatoid arthritis (RA) recommends that people with RA and disease flares, or possible drug related side effects should receive advice within 1 working day of contacting the rheumatology service. In 2016 audit data from England and Wales show that 96% of trusts report being able to provide patients with a telephone advice line but no further detail on these services was available (2). Objectives: Data from our patient advice line were collected over a 6 month period. The objective was to understand who was using the helpline, the speed of our response, how much of the workload could be managed by nursing staff and the clinical and financial impact. Methods: All patient calls made to our patient helpline were recorded and data were collected prospectively on patient demographics, disease, purpose of call, response time and the cost and revenue produced. Patient feedback was collected via a questionnaire. Data were collected from April 2016 to November 2016. Results: 150 patient calls were responded to. 108 calls were from females and were 42 from males. The majority of patients had RA (75/150). Other conditions are displayed in the graph below. The majority of calls were regarding a flare of their condition or medication queries (79/180 and 39/180 respectively) with some patients calling for more than one reason. 83% of calls were answered within 24 hours. A clinical nurse specialist is available to respond to calls over weekends. Income generated from responding to calls by the department was £ 1900 per month. Expenditure was £ 1650 per month. Patient satisfaction was high with 130/150 stating the main reason for the call was answered to their satisfaction (7 stating no, 13 not stated). of patients with RA are women, as 36.36% of EA and 50.96% of PA; Most of the patients are over 55y. In all indications, the range of 36-54y is the one that present a higher percentage of patients. For the Kaplan-Meier survival analysis, the complete set of BT that each patient had received was analyze independently, considering 1206 cases. Table 1 shows average time and percentage survival at 1st year After 1 year, ETN showed the higher rates of survival in RA (98.5%); IFX (100%), and ETN (99%) in PA; and GOLI (100%) followed by ETN (95.8%) in EA. Those BT were used to compare survival curves, finding differences in all cases (α=0.05) except in IFXvsETN in RA; ETNvsIFX in PA; and IFXvs GOLI in EA. Analysis after 5 years showed that the higher survival rates were for IFX in RA (94.4%) and PA (94.7%) and for ETN in EA (89.4%) Conclusions: BTs with highest survival rates are ETN and IFX for RA and Aps; In EA, GOLI presents a higher rate at 1-year, but at 5-year is overcome by ETN Standardized information is crucial to assess the global impact of BT. CH analysis reveals clinical practices which describe the effectiveness of treatments in the world, which can help in the decision-making process
Conclusions

